Lysosomal cystine governs ferroptosis sensitivity in cancer via cysteine stress response.
Lysosomal cystine governs ferroptosis sensitivity in cancer via cysteine stress response.
复制标题
溶酶体胱氨酸通过半胱氨酸应激反应控制癌症中的铁死亡敏感性。
DOI:
10.1016/j.molcel.2023.08.004
复制
发表时间:
2023
期刊:
影响因子:
16
通讯作者:
Qian,Shu-Bing
中科院分区:
文献类型:
--
作者:
Swanda,RobertV;Ji,Quanquan;Wu,Xincheng;Yan,Jingyue;Dong,Leiming;Mao,Yuanhui;Uematsu,Saori;Dong,Yizhou;Qian,Shu-Bing
The amino acid cysteine and its oxidized dimeric form cystine are commonly believed to be synonymous in metabolic functions. Cyst(e)ine depletion not only induces amino acid response but also triggers ferroptosis, a non-apoptotic cell death. Here, we report that unlike general amino acid starvation, cyst(e)ine deprivation triggers ATF4 induction at the transcriptional level. Unexpectedly, it is the shortage of lysosomal cystine, but not the cytosolic cysteine, that elicits the adaptative ATF4 response. The lysosome-nucleus signaling pathway involves the aryl hydrocarbon receptor (AhR) that senses lysosomal cystine via the kynurenine pathway. A blockade of lysosomal cystine efflux attenuates ATF4 induction and sensitizes ferroptosis. To potentiate ferroptosis in cancer, we develop a synthetic mRNA reagent, CysRx, that converts cytosolic cysteine to lysosomal cystine. CysRx maximizes cancer cell ferroptosis and effectively suppresses tumor growthin vivo. Thus, intracellular nutrient reprogramming has the potential to induce selective ferroptosis in cancer without systematic starvation.